Detke Michael J. 4
4 · Cortexyme, Inc. · Filed Aug 12, 2021
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
Detke Michael J.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-08-10$2.23/sh+10,000$22,300→ 10,000 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-10−10,000→ 92,352 totalExercise: $2.23Exp: 2028-11-27→ Common Stock (10,000 underlying) - Sale
Common Stock
2021-08-10$100.00/sh−10,000$1,000,000→ 0 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2021.
- [F2]The option will vest as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.